Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China
出版年份 2018 全文链接
标题
Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China
作者
关键词
Cancer, Chemotherapy, Immunobalance, Immunostimulant, Lentinan
出版物
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-24
DOI
10.1007/s00432-018-2718-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
- (2018) Anne-Sophie Hamy et al. BRITISH JOURNAL OF CANCER
- Fungal mediated innate immune memory, what have we learned?
- (2018) Jessica Quintin SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
- (2018) Neil E. Kay et al. Expert Review of Hematology
- Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy
- (2017) Hua Zheng et al. Immunotherapy
- Complete response of metastatic gastric cancer to chemoimmunotherapy
- (2017) Kenji Ina et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
- (2017) H. van Meir et al. OncoImmunology
- Anti-diabetic polysaccharides from natural sources: A review
- (2016) Peng-Cheng Wang et al. CARBOHYDRATE POLYMERS
- Mushroom heteropolysaccharides: A review on their sources, structure and biological effects
- (2016) Andrea C. Ruthes et al. CARBOHYDRATE POLYMERS
- β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance
- (2016) Boris Novakovic et al. CELL
- In VitroExperimental Model of Trained Innate Immunity in Human Primary Monocytes
- (2016) Siroon Bekkering et al. Clinical and Vaccine Immunology
- Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity
- (2016) Qian Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cellsviaactivating ROS-TXNIP-NLRP3 inflammasome
- (2015) Wei Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Induction of apoptosis in S180 tumour bearing mice by polysaccharide from Lentinus edodes via mitochondria apoptotic pathway
- (2015) Yu Zhang et al. Journal of Functional Foods
- Molecular Markers for Breast Cancer: Prediction on Tumor Behavior
- (2014) Bruna Karina Banin Hirata et al. DISEASE MARKERS
- Radiation therapy: A major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria
- (2014) Samira B.L. Makanjuola et al. RADIOTHERAPY AND ONCOLOGY
- mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity
- (2014) S.-C. Cheng et al. SCIENCE
- Emerging Therapies for Glioblastoma
- (2014) Alissa A. Thomas et al. JAMA Neurology
- The Use of Lentinan for Treating Gastric Cancer
- (2013) Kenji Ina et al. Anti-Cancer Agents in Medicinal Chemistry
- Intestinal Anti-Inflammatory Activity of Lentinan: Influence on IL-8 and TNFR1 Expression in Intestinal Epithelial Cells
- (2013) Yosuke Nishitani et al. PLoS One
- Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
- (2012) Jessica Quintin et al. Cell Host & Microbe
- Immunomodulatory β-Glucan fromLentinus edodesActivates Mitogen-activated Protein Kinases and Nuclear Factor-κB in Murine RAW 264.7 Macrophages
- (2011) Xiaojuan Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune modulating effects of β-glucan
- (2010) E Angela Murphy et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started